Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04650854
PHASE3

A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

Sponsor: UCB Biopharma SRL

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the safety, tolerability and efficacy of additional 6-week treatment cycles with rozanolixizumab in study participants with generalized myasthenia gravis (gMG).

Official title: An Open-Label Extension Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

165

Start Date

2021-02-03

Completion Date

2024-01-25

Last Updated

2026-08-20

Healthy Volunteers

No

Interventions

DRUG

Rozanolixizumab

Rozanolixizumab will be administered by subcutaneous infusion in dosage regimen 1 or 2.

Locations (69)

Mg0007 50092

Orange, California, United States

Mg0007 50099

San Francisco, California, United States

Mg0007 50122

Miami, Florida, United States

Mg0007 50120

Miami, Florida, United States

Mg0007 50073

Tampa, Florida, United States

Mg0007 50075

Augusta, Georgia, United States

Mg0007 50323

Honolulu, Hawaii, United States

Mg0007 50114

Indianapolis, Indiana, United States

Mg0007 50121

Lexington, Kentucky, United States

Mg0007 50077

New York, New York, United States

Mg0007 50090

Winston-Salem, North Carolina, United States

Mg0007 50096

Philadelphia, Pennsylvania, United States

Mg0007 50113

Houston, Texas, United States

Mg0007 50071

Edmonton, Canada

Mg0007 50066

Montreal, Canada

Mg0007 50124

Montreal, Canada

Mg0007 50070

Québec, Canada

Mg0007 50069

Toronto, Canada

Mg0007 40125

Ostrava - Poruba, Czechia

Mg0007 40124

Prague, Czechia

Mg0007 40128

Aalborg, Denmark

Mg0007 40127

Aarhus, Denmark

Mg0007 40126

Copenhagen, Denmark

Mg0007 40129

Bordeaux, France

Mg0007 40360

Limoges, France

Mg0007 40132

Nice, France

Mg0007 40133

Paris, France

Mg0007 40131

Strasbourg, France

Mg0007 20160

Tbilisi, Georgia

Mg0007 20161

Tbilisi, Georgia

Mg0007 20163

Tbilisi, Georgia

Mg0007 20164

Tbilisi, Georgia

Mg0007 20165

Tbilisi, Georgia

Mg0007 40134

Essen, Germany

Mg0007 40140

Göttingen, Germany

Mg0007 40139

Jena, Germany

Mg0007 40078

Leipzig, Germany

Mg0007 40177

Münster, Germany

Mg0007 40283

Bologna, Italy

Mg0007 40144

Milan, Italy

Mg0007 40307

Naples, Italy

Mg0007 40146

Pavia, Italy

Mg0007 40148

Roma, Italy

Mg0007 40150

Roma, Italy

Mg0007 20035

Bunkyō City, Japan

Mg0007 20068

Chiba, Japan

Mg0007 20078

Hanamaki-shi, Japan

Mg0007 20079

Hiroshima, Japan

Mg0007 20075

Kobe, Japan

Mg0007 20071

Nagasaki, Japan

Mg0007 20077

Sendai, Japan

Mg0007 20070

Shinjuku-ku, Japan

Mg0007 20076

Shinjuku-ku, Japan

Mg0007 20032

Suita, Japan

Mg0007 40155

Gdansk, Poland

Mg0007 40154

Lodz, Poland

Mg0007 40151

Lublin, Poland

Mg0007 40153

Poznan, Poland

Mg0007 20169

Novosibirsk, Russia

Mg0007 20001

Saint Petersburg, Russia

Mg0007 20028

Saint Petersburg, Russia

Mg0007 20055

Saint Petersburg, Russia

Mg0007 40467

Niš, Serbia

Mg0007 40160

Barcelona, Spain

Mg0007 40157

L'Hospitalet de Llobregat, Spain

Mg0007 40350

Murcia, Spain

Mg0007 40308

San Sebastián de los Reyes, Spain

Mg0007 20081

Taipei, Taiwan

Mg0007 20086

Taipei, Taiwan